Cubosomes: A Novel Carrier for Transdermal Drug Delivery

The drug delivery systems

  • Avantika Dhadwal Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P-176031
  • Dev Raj Sharma Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P-176031
  • Vinay Pandit Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P-176031
  • Mahendra Singh Ashawat Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P-176031
  • Pravin Kumar Department of Pharmaceutics, Laureate Institute of Pharmacy, Kathog, H.P-176031


Cubosomes are square and rounded particles with internal cubic lattice. Cubosomes are thermodynamically stable and consist of honeycombed (cavernous) structures separating two internal aqueous channels and a large interfacial area. Cubosomes are nanoparticles which are self assembled liquid crystalline particles of certain surfactants with proper ratio of water with microstructure that provides unique properties of practical interest. Bicontinuous cubic liquid crystalline phase is optically clear and very viscous material has the unique structure at nanometer scale. The word bicontinuous refers to the division of the two continuous but non-intersecting aqueous regions by lipid bilayer that is twisted into space filling structure. Hydrating a surfactant or polar lipid that forms cubic phase and then dispersing a solid like phase into smaller particles usually forms a cubosomes. Self-assembled cubosomes as active drug delivery systems are receiving more and more attention and interest after the first discovery and nomination. They exhibit different internal cubic structure and composition with different drug-loading modalities. It has high internal surface area and cubic crystalline structures, relatively simple preparation method, biodegradability of lipids, the ability of encapsulating hydrophobic, hydrophilic and amphiphilic substances, targeting and controlled release of bioactive agents. Cubosomes are having wide range of applications in various fields and they can be characterized by various evaluation parameters. So, Cubosomes are gaining more attention in pharmaceutical field.

Keywords: Cubosomes, Liquid crystal, drug-loading, hydrophilic, hydrophobic, amphiphilic.

Keywords: Cubosomes, Liquid crystal, drug-loading, hydrophilic, hydrophobic, amphiphilic


Download data is not yet available.


[1] Rarokar NR, Khedekar PB. Cubosomes: a vehicle for delivery of various therapeutic agents. MOJ Toxicol. 2018; 4:19‒21.
[2] Shah JC, Sadhale Y, Chilukuri DM. Cubic phase gels as drug delivery systems. Advanced drug delivery reviews. 2001;47:229-250.
[3] Drummond CJ, Fong C. Surfactant self assembly objects as novel drug delivery vehicles. current Opinion colloid Interface science. 2000;4:449-456.
[4] Sen R, Gupta R, Singh S, Mantry S, Das S. A Review on Cubosome and Virosome: the novel drug delivery system. UJPSR. 2017;3:24-33.
[5] Varde NM, Mehta NK, Thakor NM, Shah VA, Upadhyay UM. Phytosomes: a potential phospholipid nanoparticulate carrier. Pharmacie Globale (IJCP). 2012;10:1-7.
[6] %. Drummond CJ, Fong C. Surfactant self assembly objects as novel drug delivery vehicles. current Openion colloid Interface science. 2000;4:449-456.
[7] Tilekar KB, Khade PH, Shitole MH, Jograna MB, Dr. Patil RY. Cancer Oriented Cubosomes -A Review. International Journal for Pharmaceutical Research Scholars (IJPRS). 2014;3:198-210.
[8] Bhosale RR, Osmani RA, Harkare BR, Ghodake PP. Cubosomes: the Inimitable Nanoparticulate Drug Carriers. Scholars Academic Journal of Pharmacy. 2013;2:481-6.
[9] Anbarasan B, Grace XF, Shanmuganathan S. An overview of cubosomes—smart drug delivery system. Sri Ramachandra Journal of Medicine. 2015;8:1-4.
[10] Almeida JD, Brand CM, Edwards DC, Health TD: Formation of virosomes from influenza submits and liposomes. Lancet. 1975;306:899-901.
[11] Spicer PT, Lynch ML, Visscher M, Hoath S. Bicontinuous cubic liquid crystalline phase and cubosome personal care delivery systems. Personal Care Delivery Systems and Formulations. 2003.
[12] Daware SU, Saudagar RB. Formulation and Development of Cubosome Loaded Emulgel- A Review. International Journal of ChemTech Research. 2017;10:918-924.
[13] Tilekar K, Khade P, Kakade S, Kotwal S, Patil RY. "Cubosomes- A Drug Delivery System". International Journal of Pharmaceutical, Chemical and Biological Sciences. 2014; 4:812-824.
[14] Hundekar Y, Saboji JK, Patil SM, Nanjwade BK. Preparation and Evaluation Of Diclofenac Sodium Cubosome for Percutaneous administration. World Journal of Pharmacy and Pharmaceutical Sciences. 2014;3:523-539.
[15] Jain A, Chauhan JS, Budhwani AK. Cubosome: a novel approach for nanotechnology. 2011;2:19-21.
[16] Norlén L, Al-Amoudi A. Stratum corneum keratin structure, function, and formation: the cubic rod-packing and membrane templating model. Journal of Investigative Dermatology. 2004 ;123:715-32.
[17] Esposito E, Cortesi R, Drechsler M, Paccamiccio L, Mariani P, Contado C, Stellin E, Menegatti E, Bonina F, Puglia C. Cubosome dispersions as delivery systems for percutaneous administration of indomethacin. Pharmaceutical research. 2005; 22: 2163-73.
[18] Thadanki M, Kumari PS, Prabha KS. Overview of cubosomes: a nano particle. Int J Res Pharm Chem. 2011;1:535-41.
[19] Luzzati V, Gulik Kryzwicki T, Rivas E, Reiss-Husson F, Rand RP. X-ray study of model systems: structure of the lipid-water phases in correlation with the chemical composition of the lipids. The Journal of general physiology. 1968; 51:37-43.
[20] Spicer PT, Hayden KL, Lynch ML, Ofori-Boateng A, Burns JL. Novel Process for Producing Cubic Liquid Crystalline Nanoparticles (Cubosomes). Langmuir. 2001; 17: 5748-5756.
[21] Spicer PT, Small WB, Lynch ML, Burns JL. Dry powder precursors of cubic liquid crystalline nanoparticles (Cubosomes). Journal of Nanoparticle Research. 2002; 4: 297-311.
[22] Montis C, Castroflorio B, Mendozza M, Salvatore A, Berti D, Baglioni P. Magneto cubosomes for the delivery and controlled release of therapeutics. Journal of colloid and interface science. 2015;449:317-26.
[23] Murgia S, Falchi AM, Meli V, Schillén K, Lippolis V, Monduzzi M, Rosa A, Schmidt J, Talmon Y, Bizzarri R, Caltagirone C. Cubosome formulations stabilized by a dansyl-conjugated block copolymer for possible nanomedicine applications. Colloids and Surfaces B: Biointerfaces. 2015;129:87-94.
[24] Lutton ES. Phase behavior of aqueous systems of monoglycerides. Journal of the American Oil Chemists Society. 1965; 42:1068-70.
[25] Kulkarni CV, Wachter W, Iglesias-Salto G, Engelskirchen S, Ahualli S. Monoolein: a magic lipid?. Physical Chemistry Chemical Physics. 2011;13: 3004-21.
[26] Boyd BJ, Whittaker DV, Khoo SM, Davey G. Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems. International journal of pharmaceutics. 2006; 309: 218-26.
[27] Guillot S, Salentinig S, Chemelli A, Sagalowicz L, Leser ME, Glatter O. Influence of the stabilizer concentration on the internal liquid crystalline order and the size of oil-loaded monolinolein-based dispersions. Langmuir. 2010; 26: 6222-9.
[28] Chong JY, Mulet X, Boyd BJ, Drummond CJ. Steric stabilizers for cubic phase lyotropic liquid crystal nanodispersions (cubosomes). In Advances in planar lipid bilayers and liposomes 2015;21:131-187.
[29] Wadsten-Hindrichsen P, Bender J, Unga J, Engström S. Aqueous self-assembly of phytantriol in ternary systems: effect of monoolein, distearoylphosphatidylglycerol and three water-miscible solvents. Journal of colloid and interface science. 2007;315:701-13.
[30] Zhai J, Waddington L, Wooster TJ, Aguilar MI, Boyd BJ. Revisiting β-Casein as a stabilizer for lipid liquid crystalline nanostructured particles. Langmuir. 2011;27:14757-66.
[31] Uyama M, Nakano M, Yamashita J, Handa T. Useful modified cellulose polymers as new emulsifiers of cubosomes. Langmuir. 2009;25:4336-8.
[32] Spicer PT. Cubosome formation via dilution: Kinetics effects and consumer product implication. American Chemical Society. 2013; 861:346-359.
[33] Bansal S, Kashyap CP, Aggarwal G, Harikumar SL. A comparative review on vesicular drug delivery system and stability issues. Int J Res Pharm Chem. 2012;2:704-13.
[34] Rizwan SB, Dong YD, Boyd BJ, Rades T, Hook S. Characterisation of bicontinuous cubic liquid crystalline systems of phytantriol and water using cryo field emission scanning electron microscopy (cryo FESEM). Micron. 2007; 38:478-85.
[35] Bei D, Meng J, Youan BB. Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine. 2010; 5:1385-99.
[36] Spicer PT. Cubosome processing industrial nanoparticle technology development. Chemical Engineering Research Design. 2005; 83:1283-86.
[37] Nanjwade BK, Hundekar YR, Kamble MS, Srichana T. Development of cuboidal nanomedicine by nanotechnology. Austin J Nanomed Nanotechnol. 2014; 2:1023.
[38] Boyd BJ. Characterisation of drug release from cubosomes using the pressure ultrafiltration method. International journal of pharmaceutics. 2003;260:239-47.
[39] Lai J, Chen J, Lu Y, Sun J, Hu F, Yin Z, Wu W. Glyceryl monooleate/poloxamer 407 cubic nanoparticles as oral drug delivery systems: I. In vitro evaluation and enhanced oral bioavailability of the poorly water-soluble drug simvastatin. AAPS PharmSciTech. 2009;10:960.
[40] Lee KW, Nguyen TH, Hanley T, Boyd BJ. Nanostructure of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs. International journal of pharmaceutics. 2009;365:190-9.
[41] Nguyen TH, Hanley T, Porter CJ, Boyd BJ. Nanostructured liquid crystalline particles provide long duration sustained-release effect for a poorly water soluble drug after oral administration. Journal of controlled release. 2011;153:180-6.
[42] Clogston J, Caffrey M. Controlling release from the lipidic cubic phase. Amino acids, peptides, proteins and nucleic acids. Journal of controlled release. 2005;107:97-111.
[43] Lynch ML, Ofori-Boateng A, Hippe A, Kochvar K, Spicer PT. Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants. Journal of colloid and interface science. 2003;260:404-13.
[44] Gurfinkel J, Aserin A, Garti N. Interactions of surfactants in nonionic/anionic reverse hexagonal mesophases and solubilization of α-chymotrypsinogen A. Colloids and Surfaces A: Physicochemical and Engineering Aspects. 2011;392:322-8.
[45] Caboi F, Amico GS, Pitzalis P, Monduzzi M, Nylander T, Larsson K. Addition of hydrophilic and lipophilic compounds of biological relevance to the monoolein/water system. I. Phase behavior. Chemistry and physics of lipids. 2001;109:47-62.
[46] Liu Q, Dong YD, Hanley TL, Boyd BJ. Sensitivity of nanostructure in charged cubosomes to phase changes triggered by ionic species in solution. Langmuir. 2013;29:14265-73.
[47] Shah MH, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices. European journal of pharmaceutics and biopharmaceutics. 2007;67:166-74.
[48] Landh T. Phase behavior in the system pine needle oil monoglycerides-Poloxamer 407-water at 20. degree. The journal of physical chemistry. 1994;98:8453-67.
[49] Nakano M, Sugita A, Matsuoka H, Handa T. Small-angle X-ray scattering and 13C NMR investigation on the internal structure of “cubosomes”. Langmuir. 2001 ;17:3917-22.
[50] Driever CD, Mulet X, Waddington LJ, Postma A, Thissen H, Caruso F, Drummond CJ. Layer-by-layer polymer coating on discrete particles of cubic lyotropic liquid crystalline dispersions (cubosomes). Langmuir. 2013;29:12891-900.
[51] Kwon TK, Kim JC. Complex coacervation-controlled release from monoolein cubic phase containing silk fibroin and alginate. Biomacromolecules. 2010 ;12:466-71.
[52] Deshpande S, Venugopal E, Ramagiri S, Bellare JR, Kumaraswamy G, Singh N. Enhancing cubosome functionality by coating with a single layer of poly-ε-lysine. ACS applied materials & interfaces. 2014;6:17126-33.
[53] Nilsson C, Østergaard J, Larsen SW, Larsen C, Urtti A, Yaghmur A. PEGylation of Phytantriol-Based Lyotropic Liquid Crystalline Particles. The Effect of Lipid Composition, PEG Chain Length, and Temperature on the Internal Nanostructure. Langmuir. 2014;30:6398-407.
[54] Bhosale RR, Osmani RA, Harkare BR, Ghodake PP. Cubosomes: the inimitable nanoparticulate drug carriers. Scholars Academic Journal of Pharmacy. 2013;2:481-6.
[55] Bei D, Meng J, Youan BB. Engineering nanomedicines for improved melanoma therapy: progress and promises. Nanomedicine. 2010;:1385-99.
[56] Potphode VR, Deshmukh AS, Mahajan VR. Self-Micro Emulsifying Drug Delivery System: An Approach for Enhancement of Bioavailability of Poorly Water Soluble Drugs. Asian Journal of Pharmacy and Technology. 2016;6:159-68.
[57] Hundekar YR, Saboji JK, Patil SM, Nanjwade BK. Preparation and evaluation of diclofenac sodium cubosomes for percutaneous administration. World journal of pharmacy and pharmaceutical sciences. 2014;3:523-39.
1613 Views | 888 Downloads
How to Cite
Dhadwal A, Sharma D, Pandit V, Ashawat M, Kumar P. Cubosomes: A Novel Carrier for Transdermal Drug Delivery. JDDT [Internet]. 15Jan.2020 [cited 1Dec.2021];10(1):123-30. Available from: